Cited by 53Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsFunctional Brain Connectivity Studies

Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer’s disease

Open access
Habib, Mirette, Mak, Elijah, Gabel, Silvy, Su, Li, Williams, Guy, Waldman, Adam, Wells, Katie, Ritchie, Karen +2 more·2017·Ageing Research Reviews

Abstract

It is well established that the neurodegenerative process of Alzheimer's disease (AD) begins many years before symptom onset. This preclinical phase provides a crucial time-window for therapeutic intervention, though this requires biomarkers that could evaluate the efficacy of future disease-modification treatments in asymptomatic individuals. The last decade has witnessed a proliferation of studies characterizing the temporal sequence of the earliest functional and structural brain imaging changes in AD. These efforts have focused on studying individuals who are highly vulnerable to develop AD, such as those with familial genetic mutations, susceptibility genes (i.e. apolipoprotein epsilon-4 allele), and/or a positive family history of AD. In this paper, we review the rapidly growing literature of functional imaging changes in cognitively intact individuals who are middle-aged: positron emission tomography (PET) studies of amyloid deposition, glucose metabolism, as well as arterial spin labeling (ASL), task-dependent, resting-state functional magnetic resonance imaging (fMRI) and magnetic resonance spectroscopy (MRS) studies. The prevailing evidence points to early brain functional changes in the relative absence of cognitive impairment and structural atrophy, although there is marked variability in the directionality of the changes, which could, in turn, be related to antagonistic pleiotropy early in life. A common theme across studies relates to the spatial extent of these changes, most of which overlap with brain regions that are implicated in established AD. Notwithstanding several methodological caveats, functional imaging techniques could be preferentially sensitive to the earliest events of AD pathology prior to macroscopic grey matter loss and clinical manifestations of AD. We conclude that while these techniques have great potential to serve as biomarkers to identify at-risk individuals, more longitudinal studies with greater sample size and robust correction for multiple comparisons are still warranted to establish their utility.

Integrity signals

Registry

Crossref · 10.1016/j.arr.2017.03.004

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Habib, M., Mak, E., Gabel, S., Su, L., Williams, G., Waldman, A., Wells, K., Ritchie, K., Ritchie, C., & O’Brien, J. T.
Affiliations
  • Centre for Mental Health (GB)
  • University of Cambridge (GB)
  • University of Edinburgh (GB)
  • Inserm (FR)
Venue
Ageing Research Reviews
Publisher
Elsevier BV
Published
2017-07
Volume
36
Pages
88-104
ISSN
1568-1637 (ISSN-L)
OpenAlex
W2603457264
Cited by
53
References
8
Citations by year
2026: 1 · 2025: 6 · 2024: 6 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 7 · 2019: 5 · 2018: 8 · 2017: 1
FWCI
0.87
Type
journal article
Language
en
Open access
Locations
  • Ageing Research Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Funders
  • National Institute for Health and Care Research (RG64473)
  • NIHR Cambridge Biomedical Research Centre (RG64473)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
Keywords
Alzheimer's disease, preclinical Alzheimer's disease, at-risk individuals, middle-aged adults, functional neuroimaging, amyloid deposition, glucose metabolism, arterial spin labeling, resting-state fMRI, magnetic resonance spectroscopy, antagonistic pleiotropy, biomarkers, disease-modifying therapy
MeSH terms
Adult, Alzheimer Disease, Brain, Health Status, Humans, Middle Aged, Risk Factors, Apolipoprotein E4, Functional Neuroimaging, Cognitive Dysfunction, Gray Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review